Mammoth Biosciences

Mammoth Biosciences is a biotechnology company that detects nucleic acids on DNA and RNA without the need for related equipment, committed to making CRISPR-driven search engines the preferred platform for disease detection. Mammoth Biosciences is leveraging the diversity of nature to drive the next generation of CRISPR products. By discovering and developing novel CRISPR systems, the company is unlocking the full potential of its platform to read and write the code of life. Mammoth Biosciences aims to democratize disease detection through a simple and affordable point-of-care testing method capable of detecting multiple conditions simultaneously and in real-time. By utilizing its internal R&D and exclusive licensing of Cas12, Cas13, and Cas14, Mammoth Biosciences can provide enhanced diagnostic and genomic editing capabilities for life science research, healthcare, biodefense, and more.